What does VIXEN BIOSYSTEMS do?

VIXEN BIOSYSTEMS is a research organisation in Gent. Private Limited, started on 1 January 1981, 1 establishment.

What is the address of VIXEN BIOSYSTEMS?

The registered office of VIXEN BIOSYSTEMS is located at Bollebergen 2 B, 9052 Gent.

Is VIXEN BIOSYSTEMS still active?

Yes. According to the CBE (31 October 2026) VIXEN BIOSYSTEMS is active, legal situation “Normale toestand”, started on 1 January 1981.

Is VIXEN BIOSYSTEMS registered on Peppol?

Yes, VIXEN BIOSYSTEMS is registered on the Peppol network with ID 0208:0421258924.

What is the enterprise number of VIXEN BIOSYSTEMS?

The enterprise number of VIXEN BIOSYSTEMS is BE0421258924.

When was VIXEN BIOSYSTEMS founded?

VIXEN BIOSYSTEMS was founded on 1 January 1981.

Who are the directors of VIXEN BIOSYSTEMS?

According to the 2025 annual accounts, the directors of VIXEN BIOSYSTEMS are: 22LL CommV, L.e.a.f. Management BV.

Is VIXEN BIOSYSTEMS a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1981; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did VIXEN BIOSYSTEMS make in 2025?

VIXEN BIOSYSTEMS recorded a loss after taxes of € 96,013 in financial year 2025.

What is the revenue of VIXEN BIOSYSTEMS?

As a small company, VIXEN BIOSYSTEMS is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 150,482.

VIXEN BIOSYSTEMS (Private Limited) - Gent - BE0421258924

Dossier VIXEN BIOSYSTEMS, printed on 1 November 2026 from databakkes.be/en/0421258924/vixen-biosystems. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Two loss years in a row NBB

Negative result in 2024 and 2025.

Financials

Financial year 2025

VIXEN BIOSYSTEMS from Gent, company number BE0421258924, closed financial year 2025 with a result of € -96,013 after tax. For that financial year VIXEN BIOSYSTEMS recorded a gross margin of € 150,482 and equity of € 154,851. Compared with financial year 2024, the result moved from € -31,061 to € -96,013. The company made a loss. The buffer is growing. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.

What it is worth Growing

€ 154,851

▲ € 134,391 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -96,013

▼ 209 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 506,230

▲ € 468,535 vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -62,410.

People and assets in 2025

Wage cost

€ 192,656

Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 37,669

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 801,880

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 55,575

▲ € 55,562 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 25,518

▲ € 24,516 vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 16,215 Gross margin 2022: € 16,215 First fiscal year in the series	€ 13,163 Gross margin 2023: € 13,163 ▼ 19% vs 2022 (€ 16,215) Unfavourable step	€ -24,727 Gross margin 2024: € -24,727 ▼ € 37,890 vs 2023 (€ 13,163) Unfavourable step	€ 150,482 Gross margin 2025: € 150,482 ▲ € 175,210 vs 2024 (€ -24,727) Favourable step	▲ € 175,210
Profit after taxes	€ 14,302 Profit after taxes 2022: € 14,302 First fiscal year in the series	€ 12,588 Profit after taxes 2023: € 12,588 ▼ 12% vs 2022 (€ 14,302) Unfavourable step	€ -31,061 Profit after taxes 2024: € -31,061 ▼ € 43,649 vs 2023 (€ 12,588) Unfavourable step	€ -96,013 Profit after taxes 2025: € -96,013 ▼ € 64,952 vs 2024 (€ -31,061) Unfavourable step	▼ € 64,952
Equity	€ 55,018 Equity 2022: € 55,018 First fiscal year in the series	€ 67,606 Equity 2023: € 67,606 ▲ 23% vs 2022 (€ 55,018) Favourable step	€ 20,460 Equity 2024: € 20,460 ▼ 70% vs 2023 (€ 67,606) Unfavourable step	€ 154,851 Equity 2025: € 154,851 ▲ € 134,391 vs 2024 (€ 20,460) Favourable step	▲ € 134,391
Total debts	€ 9,450 Total debts 2022: € 9,450 First fiscal year in the series	€ 7,399 Total debts 2023: € 7,399 ▼ 22% vs 2022 (€ 9,450) Favourable step	€ 17,235 Total debts 2024: € 17,235 ▲ 133% vs 2023 (€ 7,399) Unfavourable step	€ 1,034,833 Total debts 2025: € 1,034,833 ▲ € 1 million vs 2024 (€ 17,235) Unfavourable step	▲ € 1 million
Cash	€ 7,238 Cash 2022: € 7,238 First fiscal year in the series	€ 13,580 Cash 2023: € 13,580 ▲ 88% vs 2022 (€ 7,238) Favourable step	€ 37,695 Cash 2024: € 37,695 ▲ 178% vs 2023 (€ 13,580) Favourable step	€ 506,230 Cash 2025: € 506,230 ▲ € 468,535 vs 2024 (€ 37,695) Favourable step	▲ € 468,535
Retained profit	€ 36,418 Retained profit 2022: € 36,418 First fiscal year in the series	€ 49,006 Retained profit 2023: € 49,006 ▲ 35% vs 2022 (€ 36,418) Favourable step	€ 1,860 Retained profit 2024: € 1,860 ▼ 96% vs 2023 (€ 49,006) Unfavourable step	€ -62,410 Retained profit 2025: € -62,410 ▼ € 64,270 vs 2024 (€ 1,860) Unfavourable step	▼ € 64,270
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 16,085 Dividend 2024: € 16,085 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 16,085) Unchanged	▼ 100%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 801,880 Bank debt 2025: € 801,880 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 64,468 Balance sheet total 2022: € 64,468 First fiscal year in the series	€ 75,004 Balance sheet total 2023: € 75,004 ▲ 16% vs 2022 (€ 64,468) Unchanged	€ 37,695 Balance sheet total 2024: € 37,695 ▼ 50% vs 2023 (€ 75,004) Unchanged	€ 1,189,684 Balance sheet total 2025: € 1,189,684 ▲ € 1.2 million vs 2024 (€ 37,695) Unchanged	▲ € 1.2 million

Key figures of VIXEN BIOSYSTEMS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to VIXEN BIOSYSTEMS?

What happened at VIXEN BIOSYSTEMS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 24, 2026 New annual accounts for financial year 2025: loss of € 96,013. Source: NBB ↗
2025 22LL CommV became a director. NBB
2025 L.e.a.f. Management BV became a director. NBB
Jan 1, 1981 New establishment in Gent. KBO
Jan 1, 1981 Start of the company according to the CBE. KBO

In short

From € 14,302 profit in 2022 to € 96,013 loss in 2025.

Best year ever: 2022, with € 14,302 profit.

Paid out € 16,085 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

De Vos Martin 99.9%

The stake of De Vos Martin comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

VIXEN BIOSYSTEMS

Behind VIXEN BIOSYSTEMS are 22LL CommV and L.e.a.f. Management BV. The shares are held by De Vos Martin (99.9%).

Directors

According to the 2025 annual accounts

22LL CommV

Director · represented by Steven Lauwers

since 2025

L.e.a.f. Management BV

Director · represented by Filip Delport

since 2025

Shareholders

De Vos Martin

99.9%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Bollebergen 2 B

9052 Gent

2.019.737.859

Bollebergen 2 box B

9052 Gent

Active since 1 January 1981

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0421.258.924

VAT number

BE 0421.258.924

Registered office

Bollebergen 2 B, 9052 Gent

Names & denominations

VIXEN BIOSYSTEMS

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 January 1981

Peppol

Active · Active since 1 Jan 2001

Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied

Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg

Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts

Overige technische testen en toetsen

View on CBE Public ↗ Annual accounts (NBB) ↗

VIXEN BIOSYSTEMS

Warning lights

Financials

What happened to VIXEN BIOSYSTEMS?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Details

Frequently asked questions